AAAAAA

   
Results: 1-20 |
Results: 20
SEXUAL HARASSMENT - A REVIEW OF THE LITERATURE
Authors: ODONOHUE W DOWNS K YEATER EA
Citation: W. Odonohue et al., SEXUAL HARASSMENT - A REVIEW OF THE LITERATURE, Aggression and violent behaviour, 3(2), 1998, pp. 111-128
A COMPARISON OF THE PATTERN OF INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BEFORE AND AFTER THE INTRODUCTION OF PROPHYLACTIC GANCICLOVIR THERAPY IN 1989
Authors: ATKINSON K NIVISONSMITH I DODDS A CONCANNON A MILLIKEN S DOWNS K
Citation: K. Atkinson et al., A COMPARISON OF THE PATTERN OF INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BEFORE AND AFTER THE INTRODUCTION OF PROPHYLACTIC GANCICLOVIR THERAPY IN 1989, Bone marrow transplantation, 21(7), 1998, pp. 691-695
LENOGRASTIM ADMINISTRATION TO HLA-IDENTICAL DONOR-RECIPIENT PAIRS TO ACCELERATE MARROW RECOVERY POSTTRANSPLANT
Authors: ATKINSON K FAY K NIVISONSMITH I DOWNS K
Citation: K. Atkinson et al., LENOGRASTIM ADMINISTRATION TO HLA-IDENTICAL DONOR-RECIPIENT PAIRS TO ACCELERATE MARROW RECOVERY POSTTRANSPLANT, Bone marrow transplantation, 19(1), 1997, pp. 15-21
PROVIDING CULTURALLY COMPETENT PRIMARY-CARE FOR IMMIGRANT AND REFUGEEWOMEN - A CAMBODIAN CASE-STUDY
Authors: DOWNS K BERNSTEIN J MARCHESE T
Citation: K. Downs et al., PROVIDING CULTURALLY COMPETENT PRIMARY-CARE FOR IMMIGRANT AND REFUGEEWOMEN - A CAMBODIAN CASE-STUDY, Journal of nurse-midwifery, 42(6), 1997, pp. 499-508
HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS
Authors: STYLER MJ CRILLEY P BIGGS J MOUL J COPELAN E TOPOLSKY D AVALOS B PENZA S SABOL P DOWNS K SZER J BRODSKY I MARKS DI
Citation: Mj. Styler et al., HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS, Bone marrow transplantation, 18(1), 1996, pp. 171-176
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML) - REPLY
Authors: ATKINSON K DOWNS K CONCANNON A MILLIKEN S
Citation: K. Atkinson et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML) - REPLY, Australian and New Zealand Journal of Medicine, 26(4), 1996, pp. 571-571
5-YEAR LEUKEMIA-FREE SURVIVAL OF 72-PERCENT AND 77-PERCENT FOR EARLY-STAGE ACUTE AND CHRONIC MYELOID-LEUKEMIA TREATED BY HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION
Authors: ATKINSON K DOWNS K DODDS A CONCANNON A MILLIKEN S
Citation: K. Atkinson et al., 5-YEAR LEUKEMIA-FREE SURVIVAL OF 72-PERCENT AND 77-PERCENT FOR EARLY-STAGE ACUTE AND CHRONIC MYELOID-LEUKEMIA TREATED BY HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Australian and New Zealand Journal of Medicine, 26(1), 1996, pp. 54-58
REDUCED MORBIDITY AND MORTALITY ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPROVED RESULTS WITH FLUCONAZOLE, NORFLOXACIN ANDHEPARIN
Authors: PRESGRAVE PJ DODDS AJ CONCANNON AJ MILLIKEN SM ATKINSON K DOWNS K HARKNESS J BIGGS JC
Citation: Pj. Presgrave et al., REDUCED MORBIDITY AND MORTALITY ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPROVED RESULTS WITH FLUCONAZOLE, NORFLOXACIN ANDHEPARIN, Experimental hematology, 23(8), 1995, pp. 857-857
OMISSION OF DAY 11 METHOTREXATE DOES NOT APPEAR TO INFLUENCE THE INCIDENCE OF MODERATE TO SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE, CHRONIC GRAFT-VERSUS-HOST DISEASE, RELAPSE RATE OR SURVIVAL AFTER HLA-IDENTICALSIBLING BONE-MARROW TRANSPLANTATION
Authors: ATKINSON K DOWNS K
Citation: K. Atkinson et K. Downs, OMISSION OF DAY 11 METHOTREXATE DOES NOT APPEAR TO INFLUENCE THE INCIDENCE OF MODERATE TO SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE, CHRONIC GRAFT-VERSUS-HOST DISEASE, RELAPSE RATE OR SURVIVAL AFTER HLA-IDENTICALSIBLING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(6), 1995, pp. 755-758
PROPHYLACTIC GANCICLOVIR IS MORE EFFECTIVE IN HLA-IDENTICAL FAMILY MEMBER MARROW TRANSPLANT RECIPIENTS THAN IN MORE HEAVILY IMMUNE-SUPPRESSED HLA-IDENTICAL UNRELATED DONOR MARROW TRANSPLANT RECIPIENTS
Authors: ATKINSON K ARTHUR C BRADSTOCK K DALE B DOWNS K GIBSON J JOSHUA D JUTTNER C SHAW P SHERIDAN W SZER J VOWELS M
Citation: K. Atkinson et al., PROPHYLACTIC GANCICLOVIR IS MORE EFFECTIVE IN HLA-IDENTICAL FAMILY MEMBER MARROW TRANSPLANT RECIPIENTS THAN IN MORE HEAVILY IMMUNE-SUPPRESSED HLA-IDENTICAL UNRELATED DONOR MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 16(3), 1995, pp. 401-405
PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF THE IN-VIVO USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN BONE-MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLING DONORS
Authors: BIGGS JC ATKINSON KA BOOKER V CONCANNON A DART GW DODDS A DOWNS K SZER J TURNER J WORTHINGTON R
Citation: Jc. Biggs et al., PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF THE IN-VIVO USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN BONE-MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLING DONORS, Bone marrow transplantation, 15(1), 1995, pp. 129-134
TRANSPLANTATION OF G-CSF MOBILIZED, T-CELL DEPLETED, CD34 ENRICHED HLA-IDENTICAL BLOOD STEM-CELLS TOGETHER WITH T-REPLETE BONE-MARROW IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY
Authors: ATKINSON K FAY K DOWNS K
Citation: K. Atkinson et al., TRANSPLANTATION OF G-CSF MOBILIZED, T-CELL DEPLETED, CD34 ENRICHED HLA-IDENTICAL BLOOD STEM-CELLS TOGETHER WITH T-REPLETE BONE-MARROW IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY, Blood, 86(10), 1995, pp. 1605-1605
AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY - TREATMENT-RELATED MORTALITY OF 2-PERCENT
Authors: ATKINSON K DODDS A MILLIKEN S CONCANNON A FAY K HARRIS M FLECKNOEBROWN S LIND D MCKINLEY R RUTOVITZ J ROSENFELD D HARVEY M DOWNS K FLATTERY D SONG J GREEN A QUIGLEY V HAWKINS T
Citation: K. Atkinson et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY - TREATMENT-RELATED MORTALITY OF 2-PERCENT, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 483-489
BONE-MARROW TRANSPLANTATION IN AUSTRALIA DURING 1992
Authors: ATKINSON K DOWNS K HAWKINS T
Citation: K. Atkinson et al., BONE-MARROW TRANSPLANTATION IN AUSTRALIA DURING 1992, Bone marrow transplantation, 13(6), 1994, pp. 737-739
A PROSPECTIVE DOUBLE-BLIND TRIAL TO EVALUATE THE EFFECT OF HUMAN RECOMBINANT ERYTHROPOIETIN (RHU EPO) IN PATIENTS UNDERGOING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT)
Authors: BIGGS JC DOWNS K WORTHINGTON R ATKINSON K DODDS A
Citation: Jc. Biggs et al., A PROSPECTIVE DOUBLE-BLIND TRIAL TO EVALUATE THE EFFECT OF HUMAN RECOMBINANT ERYTHROPOIETIN (RHU EPO) IN PATIENTS UNDERGOING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT), Experimental hematology, 21(8), 1993, pp. 1172-1172
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE
Authors: BRODSKY I BIGGS JC SZER J CRILLEY P ATKINSON K DOWNS K DODDS A CONCANNON AJ AVALOS BR TUTSCHKA P KAPOOR N TOPOLSKY D BULOVA SI COPELAN EA
Citation: I. Brodsky et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE, Seminars in oncology, 20(4), 1993, pp. 27-31
INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2)
Authors: STYLER M BIGGS JC TOPOLSKY D ATKINSON K BULOVA S DOWNS K KOZUCH P BRODSKY I CRILLEY P
Citation: M. Styler et al., INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2), Blood, 82(10), 1993, pp. 10000642-10000642
UNRELATED VOLUNTEER BONE-MARROW TRANSPLANTATION - INITIAL EXPERIENCE AT ST-VINCENTS-HOSPITAL, SYDNEY
Authors: ATKINSON K DODDS AJ CONCANNON AJ MILLIKEN S DOWNS K MARSHALL G WILSON F STANIFORTH D
Citation: K. Atkinson et al., UNRELATED VOLUNTEER BONE-MARROW TRANSPLANTATION - INITIAL EXPERIENCE AT ST-VINCENTS-HOSPITAL, SYDNEY, Australian and New Zealand Journal of Medicine, 23(5), 1993, pp. 450-457
CLINICAL ANALYSIS OF 125 PATIENTS WITH THE LUPUS ANTICOAGULANT
Authors: MORGAN M DOWNS K CHESTERMAN CN BIGGS JC
Citation: M. Morgan et al., CLINICAL ANALYSIS OF 125 PATIENTS WITH THE LUPUS ANTICOAGULANT, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 151-156
CHANGING RESULTS OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATIONIN PATIENTS WITH HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990
Authors: ATKINSON K BIGGS JC CONCANNON AJ DODDS AJ MILLIKEN S DOWNS K MARSHALL G WILSON F YOUNG S ASHBY M MORGAN G HARKNESS J
Citation: K. Atkinson et al., CHANGING RESULTS OF HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATIONIN PATIENTS WITH HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 181-186
Risultati: 1-20 |